Since 2022, four GLP-1 drugs, including those indicated for weight loss, have been on FDA’s drug shortage list due to extraordinarily high patient demand. The shortage has, in turn, resulted in ...

Add Yahoo as a preferred source to see more of our stories on Google. Hims & Hers’ Super Bowl ad plugs its compounded weight loss drugs as the “affordable” solution to a “sick system,” but many ...

Unless you're independently wealthy, you should be saving and investing for retirement ‒ starting, ideally, in your 20s or 30s. Sure, if you're 47 and haven't really started yet, start now. But those ...

Add Yahoo as a preferred source to see more of our stories on Google. Patients have been buying compounded weight loss drugs at lower prices than brand-name medications amid shortages of tirzepatide ...

Empower Pharmacy, a Houston-based compounding pharmacy, has attracted media attention over the last decade for its rapid expansion in the region, with the company opening two large facilities that ...

Regular contributions and compound interest work in tandem to grow your retirement account. It's OK to start small and add a little more to each contribution annually or bi-annually. The idea that ...

The Food and Drug Administration (FDA) recently declared an end to the shortage of semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), categorized broadly as GLP-1 weight loss ...

Still life of Ozempic and Wegovy. Both are injectable prescription weight loss medicines. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) As demand surges for semaglutide ...